A flow cytometry-coupled immunodetection assay using FITC-conjugated anti-PI(4,5)P2 IgM was then used to determine if HBD-3 interacted with PI(4,5)P2 on tumour cell membranes. The gene discussed is CD40LG; the disease is neoplasm.